Tower Research Capital (TRC)’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.4K | Buy |
7,198
+4,884
| +211% | +$26.7K | ﹤0.01% | 3180 |
|
|
2025
Q1 | $14.6K | Sell |
2,314
-338
| -13% | -$2.13K | ﹤0.01% | 3286 |
|
|
2024
Q4 | $10.9K | Sell |
2,652
-1,251
| -32% | -$5.15K | ﹤0.01% | 3762 |
|
|
2024
Q3 | $13K | Sell |
3,903
-3,158
| -45% | -$10.5K | ﹤0.01% | 3545 |
|
|
2024
Q2 | $21K | Buy |
7,061
+6,451
| +1,058% | +$19.2K | ﹤0.01% | 3737 |
|
|
2024
Q1 | $2.1K | Sell |
610
-6,947
| -92% | -$24K | ﹤0.01% | 5118 |
|
|
2023
Q4 | $10.1K | Buy |
7,557
+1,104
| +17% | +$1.48K | ﹤0.01% | 4290 |
|
|
2023
Q3 | $14.1K | Buy |
6,453
+4,951
| +330% | +$10.8K | ﹤0.01% | 3717 |
|
|
2023
Q2 | $3.59K | Buy |
+1,502
| New | +$3.59K | ﹤0.01% | 5024 |
|
|
2022
Q4 | – | Sell |
-9,786
| Closed | -$15K | – | 6381 |
|
|
2022
Q3 | $15K | Buy |
9,786
+5,912
| +153% | +$9.06K | ﹤0.01% | 4180 |
|
|
2022
Q2 | $11K | Sell |
3,874
-5,603
| -59% | -$15.9K | ﹤0.01% | 4392 |
|
|
2022
Q1 | $21K | Buy |
9,477
+1,160
| +14% | +$2.57K | ﹤0.01% | 3499 |
|
|
2021
Q4 | $7K | Buy |
8,317
+3,514
| +73% | +$2.96K | ﹤0.01% | 4951 |
|
|
2021
Q3 | $7K | Buy |
4,803
+616
| +15% | +$898 | ﹤0.01% | 4676 |
|
|
2021
Q2 | $10K | Buy |
4,187
+2,950
| +238% | +$7.05K | ﹤0.01% | 4403 |
|
|
2021
Q1 | $3K | Sell |
1,237
-3,991
| -76% | -$9.68K | ﹤0.01% | 4928 |
|
|
2020
Q4 | $13K | Buy |
5,228
+3,821
| +272% | +$9.5K | ﹤0.01% | 4165 |
|
|
2020
Q3 | $6K | Buy |
+1,407
| New | +$6K | ﹤0.01% | 4313 |
|
|
2019
Q4 | – | Sell |
-2,344
| Closed | -$11K | – | 4366 |
|
|
2019
Q3 | $11K | Buy |
2,344
+1,142
| +95% | +$5.36K | ﹤0.01% | 2888 |
|
|
2019
Q2 | $9K | Buy |
+1,202
| New | +$9K | ﹤0.01% | 2632 |
|